ReviewMedical oncology (Northwood, London, England)2026

Rho/PAK signaling: a key driver of anthracycline and taxane resistance in breast cancer.

Nurul Syafawani Fizal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.